IL251336B - תכשירי פרופאן–1–חומצה סולפונית {3–[5–(4–כלורו–פניל)–h1–פירולו[b–3,2] פירידין–3–קרבוניל]–4,2–דיפלואורו–פניל}–אמיד ושימושים בהם - Google Patents
תכשירי פרופאן–1–חומצה סולפונית {3–[5–(4–כלורו–פניל)–h1–פירולו[b–3,2] פירידין–3–קרבוניל]–4,2–דיפלואורו–פניל}–אמיד ושימושים בהםInfo
- Publication number
- IL251336B IL251336B IL251336A IL25133617A IL251336B IL 251336 B IL251336 B IL 251336B IL 251336 A IL251336 A IL 251336A IL 25133617 A IL25133617 A IL 25133617A IL 251336 B IL251336 B IL 251336B
- Authority
- IL
- Israel
- Prior art keywords
- phenyl
- pyrrolo
- difluoro
- propane
- carbonyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- GPXBXXGIAQBQNI-UHFFFAOYSA-N vemurafenib Chemical compound CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C=2C3=CC(=CN=C3NC=2)C=2C=CC(Cl)=CC=2)=C1F GPXBXXGIAQBQNI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16667709P | 2009-04-03 | 2009-04-03 | |
| US17605109P | 2009-05-06 | 2009-05-06 | |
| EP09175665 | 2009-11-11 | ||
| PCT/US2010/029489 WO2010114928A2 (en) | 2009-04-03 | 2010-03-31 | Compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL251336A0 IL251336A0 (he) | 2017-05-29 |
| IL251336B true IL251336B (he) | 2020-04-30 |
Family
ID=54978682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL251336A IL251336B (he) | 2009-04-03 | 2017-03-22 | תכשירי פרופאן–1–חומצה סולפונית {3–[5–(4–כלורו–פניל)–h1–פירולו[b–3,2] פירידין–3–קרבוניל]–4,2–דיפלואורו–פניל}–אמיד ושימושים בהם |
Country Status (3)
| Country | Link |
|---|---|
| HR (1) | HRP20151156T1 (he) |
| IL (1) | IL251336B (he) |
| JO (1) | JO3056B1 (he) |
-
2010
- 2010-03-31 HR HRP20151156TT patent/HRP20151156T1/hr unknown
- 2010-04-01 JO JOP/2010/0105A patent/JO3056B1/ar active
-
2017
- 2017-03-22 IL IL251336A patent/IL251336B/he active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JO3056B1 (ar) | 2017-03-15 |
| HRP20151156T1 (hr) | 2016-01-01 |
| HK1168590A1 (zh) | 2013-01-04 |
| HK1217195A1 (en) | 2016-12-30 |
| IL251336A0 (he) | 2017-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL219108A0 (en) | Propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof | |
| PL2595958T3 (pl) | Nowy sposób wytwarzania {3-[5-(4-chlorofenylo)-1 h-pirolo[2,3-b]pirydyno-3-karbonylo]-2,4-difluorofenylo}amidu kwasu propano-1-sulfonowego | |
| ZA201202024B (en) | PROPANE-1-SULFONIC ACID {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-b] PYRIDINE-3-CARBONY]-2,4-DIFLUOLOPHENYL}-AMIDE, AS WELL AS USES THEREOF | |
| IL220571A (he) | תרכובות של 3–(3–פניל–אימידאזו[5,4–b]פירידיניל)–2–אמינופירידין המותמרות ותכשירים רוקחיים המכילים אותן | |
| IL213993A (he) | תולדות 4,3,2,1–טטראהידרופירידו[3,2–b]פיראזינ–2–און ותכשירי רוקחות המכילים אותן | |
| LT3001903T (lt) | 1h-pirazolo[3,4-b]piridinai ir jų terapinis panaudojimas | |
| ZA201107836B (en) | 1,2,4-triazolo[4,3-]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors | |
| IL220432A (he) | תולדות תיאנו [b–3,2] פירידינדיון ותכשירים רוקחיים המכילים אותן | |
| PL2229391T3 (pl) | Pirydo[2,3-b]pirazyno-8-podstawione związki i ich zastosowanie | |
| PL2600719T3 (pl) | 2-Podstawione 8-alkilo-7-okso-7,8-dihydropirydo[2,3-d]pirymidyno-6-karbonitryle oraz ich zastosowania | |
| PL3415515T3 (pl) | Sposób wytwarzania {4,6-diamino-2-[1-(2-fluorobenzylo)-1H-pirazolo[3,4-b]pirydyn-3-ylo]pirymidyn-5-ylo}metylokarbaminianu metylu | |
| GB0716035D0 (en) | Golf ball | |
| IL202248A0 (en) | 3-(imidazolyl)-pyrazolo{3,4-b}pyridines, compositions comprising the same and uses thereof | |
| ZA201108885B (en) | 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates | |
| IL226095A (he) | תולדות {4–[5–(1–מתיל–h1–פיראזול–4–איל)–h1–פירולו[3,2–b]פירידינ–3–איל] פירימידינ–2–יל}אמין ותרופות המכילות אותן | |
| IL210074A0 (en) | Compositions with and process for methylmorpholin-substituted pyrido[2,3-d]pyrimidines | |
| IL197452A (he) | תולדות 3–[h1–פירולו[3,2– b]פירידינ–3–איל)]מתילידן]–אימידאזולידינ–2–און ותכשירי רוקחות המכילים אותן כחומר נגד שגשוג תאים | |
| IL219712A0 (en) | Novel solvates of methyl {4, 6 -diamino-2-[1-(2-fluorobenzyl)- 1h-pyrazolo[3,4-b] pyridin - 3 - yl] pyrimidin - 5 -yl} carbamate | |
| GB0808071D0 (en) | Golf ball dispaenser | |
| IL251336B (he) | תכשירי פרופאן–1–חומצה סולפונית {3–[5–(4–כלורו–פניל)–h1–פירולו[b–3,2] פירידין–3–קרבוניל]–4,2–דיפלואורו–פניל}–אמיד ושימושים בהם | |
| GB2441505B (en) | Golf putting cup | |
| AU2009903132A0 (en) | Personal Golf Club - N' - Golf Ball Caddy | |
| GB2478233B (en) | Golf ball | |
| AU2006904280A0 (en) | Golf buddy | |
| AU2007202797A1 (en) | Golf buddy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |